Article October 20, 2022
Fish Principal Gwilym Attwell Authors Article for Life Science Leader, "Intellectual Property Do's and Don'ts for Early-Stage Life Sciences Companies"
- Person title
The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.
Blog September 15, 2022
Legal Alert: What to Know About the USPTO's Duty of Candor Guidance Regarding FDA Submissions
Blog September 27, 2018
Four Fish Post-Grant Attorneys Named 2018 Life Science Stars by LMG Life Sciences
Blog June 13, 2018
Fish Obtains First PGR Reversal at Federal Circuit in Altaire Pharmaceuticals, Inc. v. Paragon Bioteck, Inc.
Article May 28, 2009
The Bright Side of Nuclear Winter: Opportunities in the New, New Economy
Article January 21, 2009
Technology Times: First to Invent? Prove It
Blog September 25, 2023
Federal Circuit Evaluates Enablement for Antibody Claims for the First Time Since Amgen v. Sanofi in Baxalta Inc. et al. v. Genentech, Inc.
Blog June 14, 2023
New Admission Criteria to Practice Before USPTO Designed to Foster Diversity and Promote Innovation
Blog May 19, 2023
Legal Alert: Amgen v. Sanofi
Blog May 15, 2023
Legal Alert: Minimizing Patent TRO and PI Risk in Europe
Article March 22, 2023
Principals Anita Meiklejohn and Caleb Bates Co-Author Article for One Nucleus Annual Review 2023
Blog March 17, 2023
Legal Alert: The USPTO’s Transition to Electronic Patent Issuance and Reduction in Period Between Issue Notification and Issue Date
Article March 8, 2023
Senior Principal Terry Mahn Authors Medical Device + Diagnostic Industry Article "This Company's False Compliance With CISPR 11 Resulted in a $12 Million FCA...
Article February 17, 2023
Principals Patrick Darno and Peter Fasse Author "Patent Strategies for Protecting Bioinformatics Inventions" for IAM
Article February 3, 2023
Fish & Richardson Attorneys Author IAM Article "Neglect Begets Opportunity in Femtech IP"
Blog January 17, 2023
Biosimilars 2022 Year in Review